The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from ‘excess’ ...
Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...
CVS responds by saying regulator's latest report is 'inappropriate and misleading' The drug middlemen known as pharmacy-benefit managers took another body blow from regulators on Tuesday ...
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
These include, but are not limited to, the big three drug middlemen known as pharmacy benefit managers (PBMs). According to ...
The three largest drug middlemen inflated the costs of numerous life-saving medications by billions of dollars over the past few years, the Federal Trade Commission said in a report Tuesday. The top ...
(CNN) — Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty ...